# IGC Pharma, Inc.: Form 8-K, filed Jul 6, 2026

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2026-07-06
- Accepted by EDGAR: Jul 6, 2026, 16:02 ET
- Period: 2026-06-30
- Accession: 0001185185-26-002808
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526002808/igc8k070626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518526002808/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518526002808/igc8k070626.htm

Filed Jul 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001185185-26-002808. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.